How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

529 results for

Postpartum Inpatient Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

521. How long post natally does a lady who had emergency delivery for impending eclampsia need to be monitored?

on the management of severe pre-eclampsia/eclampsia states: “ C - Anti-hypertensive medication should be continued after delivery as dictated, by the blood pressure. It may be necessary to maintain treatment for up to 3 months, although most women can have treatment stopped before this. C - Women with persisting hypertension and proteinuria at 6 weeks may have renal disease and should be considered for further investigation. Severe pre-eclampsia or eclampsia can occur in the postpartum period. Up to 44 (...) length of inpatient postnatal stay is unclear but the incidence of eclampsia and severe pre-eclampsia falls after the fourth postpartum day. The decision about discharge from hospital needs to take account of the risk of late seizures. Most women with severe pre-eclampsia or eclampsia will need inpatient care for 4 days or more following delivery. Careful review to ensure improving clinical signs is needed before discharge. [Evidence level III].” Concerning raised blood pressure postpartum, the RCOG

2007 TRIP Answers

522. Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder

for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Inpatients or outpatients with Major Depressive Disorder characterized by a recurrent Major Depressive Episode with Montgomery and Asberg Depression Rating Scale (MADRS) total score => 30 Exclusion Criteria: Patient is at immediate risk for suicidal behavior Patient with psychotic features, catatonic features, seasonal pattern or postpartum onset Patients with a current depressive episode secondary to a general medical disorder (...) Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2007 Clinical Trials

523. Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) to Primary Outcome Measures : Infant Gestational Age at Delivery [ Time Frame: At the time of delivery ] Infant Gender [ Time Frame: At the time of delivery ] Infant Race [ Time Frame: At the time of delivery ] Mean ATV Maximum Plasma Concentration (Cmax) in One Dosing Interval [ Time Frame: Pregnancy Weeks 12 to 28, 28 to 36, and 4-6 Weeks Postpartum ] Cmax = maximum observed plasma concentration of atazanavir at specified time points. Mean RTV Maximum Plasma Concentration (Cmax) in One Dosing Interval

2006 Clinical Trials

524. Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins

Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Low-Dose rtPA to Treat Blood Clots (...) to and through the blood clot that is blocking the blood flow in the vein. This is done under an x-ray machine so the radiologist can see exactly where the tube is going. Then, rtPA is injected into the clot about every 30 seconds for 15 to 30 minutes. The catheter is kept in place to maintain access to the vein for additional treatment the next day, if needed. The patient then begins treatment with heparin, either as an outpatient or an inpatient. A second venogram is done the next day. If the venogram

2003 Clinical Trials

525. Improving Health Outcomes for New Mothers and Babies

Improving Health Outcomes for New Mothers and Babies Improving Health Outcomes for New Mothers and Babies - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Improving Health Outcomes for New Mothers and Babies (...) or disease Intervention/treatment Phase Hyperbilirubinemia Jaundice Dehydration Postpartum Depression Behavioral: Home Nurse Visit Phase 3 Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 1154 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Prevention Official Title: Improving Health Outcomes for New Mothers and Babies Study Start Date : September 2006 Actual

2006 Clinical Trials

526. Clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus in pregnancy. (PubMed)

in the postpartum period. Skin and soft tissue infections accounted for 96% of cases. The most common site for a lesion was the extremities (44%), followed by the buttocks (25%), and breast (mastitis) (23%). Fifty-eight percent of patients had recurrent episodes. Sixty-three percent of patients required inpatient treatment. All MRSA isolates were sensitive to trimethoprim-sulfamethoxazole, vancomycin, and rifampin. Other antibiotics to which the isolates were susceptible included gentamicin (98 (...) Clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus in pregnancy. The objective of this study was to review the presentation and management of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) in pregnant women.This was a chart review of pregnant patients who were diagnosed with MRSA between January 1, 2000, and July 30, 2004. Data collected included demographic characteristics, clinical presentation, culture results, and pathogen

Full Text available with Trip Pro

2005 Obstetrics and Gynecology

527. Examination of Brain Serotonin Receptors in Patients With Mood Disorders

Examination of Brain Serotonin Receptors in Patients With Mood Disorders Examination of Brain Serotonin Receptors in Patients With Mood Disorders - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Examination (...) , non-FPDD. To assess the specificity of the findings in MDD to FPDD, a sample meeting criteria for MDD, currently in a depressive episode, but not FPDD will also be imaged. BIPOLAR DEPRESSED SAMPLE: Forty five subjects (ages 18 to 60) who meet DSM-IV criteria for bipolar disorder and are currently in a major depressive episode. Subjects may be inpatients or outpatients. Because effective treatment will not be discontinued for the purposes of this protocol, subjects will be identified who have never

2001 Clinical Trials

528. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

800 13. Ventricular arrhythmias and sudden cardiac death related to speci?c populations 800 13.1. Athletes. . 800 13.1.1. Screening and management 801 13.1.1.1. Screening 801 13.1.1.2. Management of arrhythmias, cardiac arrest, and syncope in athletes 801 13.2. Gender and pregnancy 801 13.2.1. QT Interval . . 801 13.2.2. Pregnancy and postpartum 802 13.2.3. Special concerns regarding speci?c arrhythmias . 802 13.3. Elderly patients 802 13.3.1. Epidemiology. 802 13.3.2. Pharmacological therapy (...) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death ACC/AHA/ESC Guidelines ACC/AHA/ESC2006guidelinesformanagementofpatientswith ventriculararrhythmiasandthepreventionofsuddencardiacdeath AreportoftheAmericanCollegeofCardiology/AmericanHeartAssociationTask ForceandtheEuropeanSocietyofCardiologyCommitteeforPracticeGuidelines (WritingCommitteetoDevelopGuidelinesforManagementofPatientsWith

2006 European Society of Cardiology

529. Promoting smoking abstinence in pregnant and postpartum patients: a comparison of 2 approaches. (PubMed)

Promoting smoking abstinence in pregnant and postpartum patients: a comparison of 2 approaches. To compare the implementation, delivery, and implications for dissemination of 2 different maternal smoking-cessation/relapse-prevention interventions in managed care environments.Healthy Options for Pregnancy and Parenting (HOPP) was a randomized, controlled efficacy trial of an intervention that bypassed the clinical setting. Stop Tobacco for OuR Kids (STORK) was a quasi-experimental effectiveness (...) study of a point-of-service intervention. Both incorporated prenatal and postnatal components.Subjects in both studies were pregnant women who either smoked currently or had quit recently. The major intervention in HOPP was telephone counseling delivered by trained counselors, whereas the STORK intervention was delivered by providers and staff during prepartum, inpatient postpartum, and well-baby visits.In HOPP, 97% of telephone intervention participants reported receiving 1 or more counselor calls

2001 The American journal of managed care

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>